#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

Why Everyone Is Drowning In Debt (and how to get out) - Cal… · Jul 13, 2026 Health & Fitness

When you're stressed and financially stretched, small purchases become a coping mechanism. Dopamine spikes from buying things provide momentary relief from the anxiety of being broke — which then deepens the financial hole. It's a feedback loop too complex for any political billboard, but possibly one of the key drivers of persistent poverty. Expand

#399 ‒ The evolution of Alzheimer's disease and dementia ca… · Jul 13, 2026 Health & Fitness

Alzheimer's and other dementias exist on a wide spectrum — from barely detectable impairment to rapid severe decline — and the disease's presentation depends heavily on the individual's brain reserve, comorbidities, and the area of brain affected. Treating it as an all-or-nothing condition misses most of the clinical picture. Expand

#399 ‒ The evolution of Alzheimer's disease and dementia ca… · Jul 13, 2026 Health & Fitness

The classic amyloid-first model of Alzheimer's pathology is being overturned. Neuroimmunological changes may precede amyloid deposition by years or decades, opening a window for anti-inflammatory intervention as early as your 30s and 40s to prevent the entire cascade from triggering. Expand

#399 ‒ The evolution of Alzheimer's disease and dementia ca… · Jul 13, 2026 Health & Fitness

Standard cognitive tests like the MoCA or MMSE are nearly useless for highly intelligent patients — many score a perfect 30 well into their condition. Real evaluation requires multi-hour neuropsychological testing, brain blood flow measurement, EEG, specialized MRI, and often amyloid and tau PET scans. Expand

#399 ‒ The evolution of Alzheimer's disease and dementia ca… · Jul 13, 2026 Health & Fitness

Forgetting names is neurologically normal and almost never a sign of Alzheimer's. The real red flag is difficulty recalling common nouns — struggling to find the word 'chair' or 'book' — because that kind of semantic memory is housed in a different, more diagnostically significant brain region. Expand

#399 ‒ The evolution of Alzheimer's disease and dementia ca… · Jul 13, 2026 Health & Fitness

Estrogen loss at menopause drives measurable cognitive decline — including memory problems, word-finding difficulties, and executive dysfunction — that is clinically indistinguishable from early Alzheimer's disease. Gayatri Devi has treated multiple women who were misdiagnosed with Alzheimer's when they actually had reversible menopause-related cognitive impairment. Expand

#399 ‒ The evolution of Alzheimer's disease and dementia ca… · Jul 13, 2026 Health & Fitness

Blood-based Alzheimer's biomarkers are validated against amyloid PET scans — but 25–44% of people over 70 have amyloid in their brains without any dementia. Diagnosing Alzheimer's from a blood test alone risks creating a massive population of 'patients in waiting' who may never develop disease. Expand

#399 ‒ The evolution of Alzheimer's disease and dementia ca… · Jul 13, 2026 Health & Fitness

Anti-amyloid monoclonal antibodies like lecanemab and donanemab can clear amyloid from the brain, but carry a greater than 40% risk of ARIA in standard protocols for APOE4 carriers. Gayatri Devi developed an ultra-slow titration protocol that reduces this risk to approximately 4%, allowing even high-risk APOE4 homozygotes to access potentially life-changing therapy. Expand

#399 ‒ The evolution of Alzheimer's disease and dementia ca… · Jul 13, 2026 Health & Fitness

Aducanumab was approved in 2021 against its FDA advisory board's recommendation because clearing amyloid didn't translate to clear clinical benefit in the trials. Gayatri Devi prescribed it anyway, applying a simple personal test: would she want it herself if she had Alzheimer's? Her answer was yes. Expand